Adriazola Semino M, Lozano Ortega J L, García Cobo E, Tejeda Báñez E, Romero Rodríguez F
Servicio de Urología, Hospital Río Carrión, Palencia, España.
Arch Esp Urol. 1992 Apr;45(3):211-3.
Forty-five patients diagnosed as having BPH and clinically diagnosed micturition disorders were entered in a therapeutic protocol. Twenty-five patients received Prazosin and the remaining 20 patients were treated with Serenoa Repens for a period of 12 weeks. The symptomatology was assessed by flowmetry and the patients were questioned as to the irritative symptoms. It can be concluded from the study that Prazosin is slightly more effective in controlling the irritative symptoms produced by BPH.
45名被诊断患有良性前列腺增生症(BPH)且临床上诊断有排尿障碍的患者进入了一个治疗方案。25名患者接受哌唑嗪治疗,其余20名患者接受锯叶棕治疗,为期12周。通过尿流率测定评估症状,并询问患者刺激性症状。从该研究可以得出结论,哌唑嗪在控制良性前列腺增生症产生的刺激性症状方面略更有效。